GEREF Drug Patent Profile

✉ Email this page to a colleague

When do Geref patents expire, and what generic alternatives are available?

Geref is a drug marketed by Emd Serono and Emd Serono Inc and is included in two NDAs.

The generic ingredient in GEREF is sermorelin acetate. There is one drug master file entry for this compound. Additional details are available on the sermorelin acetate profile page.

Summary for GEREF

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	25
Patent Applications:	296
DailyMed Link:	GEREF at DailyMed

Drug patent expirations by year for GEREF

Anatomical Therapeutic Chemical (ATC) Classes for GEREF

H01AC	Somatropin and somatropin agonists
H01A	ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
H01	PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H	Systemic hormonal preparations, excluding sex hormones and insulins

V04CD	Tests for pituitary function
V04C	OTHER DIAGNOSTIC AGENTS
V04	DIAGNOSTIC AGENTS
V	Various

US Patents and Regulatory Information for GEREF

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emd Serono	GEREF	sermorelin acetate	INJECTABLE;INJECTION	019863-001	Dec 28, 1990		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-001	Sep 26, 1997		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-002	Sep 26, 1997		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for GEREF

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-001	Sep 26, 1997	⤷ Try a Trial	⤷ Try a Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-001	Sep 26, 1997	⤷ Try a Trial	⤷ Try a Trial
Emd Serono	GEREF	sermorelin acetate	INJECTABLE;INJECTION	019863-001	Dec 28, 1990	⤷ Try a Trial	⤷ Try a Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-002	Sep 26, 1997	⤷ Try a Trial	⤷ Try a Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-002	Sep 26, 1997	⤷ Try a Trial	⤷ Try a Trial
Emd Serono	GEREF	sermorelin acetate	INJECTABLE;INJECTION	019863-001	Dec 28, 1990	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for GEREF

See the table below for patents covering GEREF around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Czechoslovakia	8406901		⤷ Try a Trial
Australia	2307584		⤷ Try a Trial
New Zealand	207658	RAT GRF (GROWTH HORMONE RELAXING FACTOR) PEPTIDES AND PHARMACEUTICAL COMPOSITIONS	⤷ Try a Trial
Germany	3585634		⤷ Try a Trial
South Korea	900006711		⤷ Try a Trial
European Patent Office	0146210	GRF ANALOGS	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for GEREF

Anatomical Therapeutic Chemical (ATC) Classes for GEREF

Make Better Decisions: Try a trial or see plans & pricing